Tag: Clinical trials
Search News
Thomas Powles named in TIME’s list of the 100 most influential people in global health this year
2nd May 2024
Professor Powles has been recognised for his transformative clinical work delivering a life-extending treatment for severe bladder cancer.
Read more
Immunotherapy drug improves survival for people with kidney cancer in landmark clinical trial
19th April 2024
Professor Tom Powles and team reveal first successful adjuvant therapy for kidney cancer in 50 years.
Read more
New treatment for mesothelioma improves survival in breakthrough clinical trial
15th February 2024
The ATOMIC-meso trial is the culmination of 20 years of research at the Barts Cancer Institute
Read more
Professor Thomas Powles selected as one of Nature’s top ten people who shaped science in 2023
15th December 2023
Professor Powles has been recognised for his transformative clinical work delivering a life-extending treatment for severe bladder cancer.
Read more
New drug combination doubles survival for people with bladder cancer
25th October 2023
Clinical trial results from BCI and Barts NHS trust provide new hope for people with bladder cancer.
Read more
Clinical trial shows tumour-starving drug improves survival of mesothelioma
16th April 2023
An innovative therapy provides new hope to patients with malignant mesothelioma – a rare but rapidly fatal type of cancer with few effective treatment options – according to results presented by Professor Peter Szlosarek and his team at Barts Cancer Institute, Queen Mary University of London.
Read more